Table 2.
Characteristics of pancreatic ductal adenocarcinoma (PDAC) recurrences.
| Author | Time to Recurrence (mo, Range) | Type of Recurrence | Intraoperative Blood Loss (mL, Range) | Operating Time (min, Range) | Hospital Stay (Days, Range) | |
|---|---|---|---|---|---|---|
| Local | Distant | |||||
| Seelig et al. [19] | 18 (4–120) | 7 | - | 200 (100–800) | 255 (150–540) | 22 (9–32) |
| Lavu et al. [1] | 32 (2–107) | 11 | - | 500 (200–4000) | NR | 6 (5–24) |
| Roeder et al. [18] | 20 (6–76) | 24 | - | NR | NR | NR |
| Thomas et al. [6] | 22 (2–86) | 6 | 15 (lung 7; liver 6; brain 1, abdominal wall 1) | NR | NR | NR |
| Strobel et al. [20] | 14,9 (11.3–22) | 41 | 4 (local + single liver metastasis) | 350 (200–500) | 275 (185–345) | 9 (7–13) |
| Miyazaki et al. [17] | 32 (7–89) | 11 | - | 867 (310–9865) | 231 (160–600) | |
| Boone et al. [15] | 35.1 (7.6–63.6) | 10 | 12 (lung 5, ovary 1, liver 6) | 300 (25–6000) | 232 (77–435) | 8 (2–28) |
| Hashimoto et al. [16] | 32 (23–103) | 8 | - | NR | NR | NR |
| Shima et al. [21] | 25.1 (12–60) | 6 | - | 465 (110–1390) | 165 (141–412) | 17 (13–30) |
| Chang et al. [23] | 13.9 (4.4–51.2) | 5 | 9 (liver 3, ovary 2, multiorgan resection 4) | NR | NR | 13 (4–29) |
| Yasukawa et al. [24] | 32 (8–74) | 0 | 12 (lung) | NR | NR | NR |
| Nakayama et al. [22] | 24 (10–31) | 11 | - | NR | NR | NR |
| Groot et al. [25] | 24.3 (9.6–83.0) | 0 | 19 (lung) | NR | NR | 3 (2–4) |
| Yamada et al. [26] | 38.6 ± 24.2 | 90 | - | 700 ± 618 | 344 ± 167 | 27.4 ± 20.0 |
| Total † | 28 (2–120) | 230 | 71 | 595 (110–9865) me | 170 (141–1860) me | 11 (2–32) me |
Mo: months (results reported in median*), IO: intraoperative; mL: milliliter; min: minutes; NR: not reported; me: median; † where individually reported.